Clinical Trial Update: ZW25 in Women With Endometrial Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial of ZW25 in women with endometrial cancer and uterine carcinosarcoma has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Uterine Carcinosarcoma

Drugs mentioned

• ZW25 (zanidatamab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Endometrial Cancer, Carcinosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2024-10-21